IRIS
AIMO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.679
AS - Asia 19.711
EU - Europa 17.264
SA - Sud America 4.479
AF - Africa 530
Continente sconosciuto - Info sul continente non disponibili 504
OC - Oceania 50
Totale 78.217
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.998
SG - Singapore 7.144
IT - Italia 5.389
RU - Federazione Russa 4.954
CN - Cina 4.873
BR - Brasile 3.484
VN - Vietnam 2.576
GB - Regno Unito 1.800
HK - Hong Kong 1.430
BD - Bangladesh 1.392
DE - Germania 1.119
CA - Canada 1.074
FR - Francia 661
SE - Svezia 572
FI - Finlandia 533
IN - India 475
UA - Ucraina 472
IE - Irlanda 459
AR - Argentina 352
MX - Messico 334
NL - Olanda 295
TR - Turchia 289
PL - Polonia 253
ID - Indonesia 230
ES - Italia 198
ZA - Sudafrica 194
EC - Ecuador 183
IQ - Iraq 182
JP - Giappone 174
IL - Israele 169
PK - Pakistan 158
CO - Colombia 123
AT - Austria 107
VE - Venezuela 96
MA - Marocco 85
AE - Emirati Arabi Uniti 82
UZ - Uzbekistan 76
DK - Danimarca 72
LT - Lituania 66
PY - Paraguay 63
CL - Cile 60
EG - Egitto 57
MY - Malesia 56
SA - Arabia Saudita 56
CR - Costa Rica 48
PE - Perù 46
TN - Tunisia 46
KE - Kenya 44
CH - Svizzera 43
PH - Filippine 39
BE - Belgio 37
JM - Giamaica 37
AU - Australia 32
UY - Uruguay 32
JO - Giordania 31
AZ - Azerbaigian 30
BO - Bolivia 30
DZ - Algeria 29
GT - Guatemala 29
HN - Honduras 28
RO - Romania 26
KZ - Kazakistan 23
CZ - Repubblica Ceca 22
NP - Nepal 22
TH - Thailandia 21
DO - Repubblica Dominicana 20
OM - Oman 19
PT - Portogallo 19
TT - Trinidad e Tobago 19
EU - Europa 17
IR - Iran 17
SV - El Salvador 17
AL - Albania 16
SK - Slovacchia (Repubblica Slovacca) 16
TW - Taiwan 16
LB - Libano 15
NI - Nicaragua 15
PA - Panama 14
ET - Etiopia 13
GR - Grecia 13
KR - Corea 13
AM - Armenia 12
BB - Barbados 12
BG - Bulgaria 12
KG - Kirghizistan 12
HU - Ungheria 11
NZ - Nuova Zelanda 11
PS - Palestinian Territory 11
GE - Georgia 10
RS - Serbia 10
CI - Costa d'Avorio 9
HR - Croazia 9
LV - Lettonia 9
MD - Moldavia 9
PR - Porto Rico 9
SN - Senegal 9
BH - Bahrain 8
BY - Bielorussia 8
GY - Guiana 8
MC - Monaco 8
Totale 77.556
Salva come PNG Salva come JPEG
Città #
Dallas 6.250
Singapore 3.716
San Jose 2.908
Ashburn 2.546
Beijing 1.783
Council Bluffs 1.634
Chicago 1.484
Los Angeles 1.473
Hong Kong 1.337
Moscow 916
Milan 865
Ho Chi Minh City 838
New York 702
Salt Lake City 616
Rome 585
Chandler 562
Buffalo 560
Santa Clara 556
Southend 543
Hanoi 505
The Dalles 468
Fairfield 462
San Mateo 451
Dublin 445
Houston 428
Phoenix 411
São Paulo 367
Wilmington 363
Woodbridge 362
Lauterbourg 360
Hefei 353
Tampa 351
Helsinki 333
Seattle 327
Cambridge 322
Elk Grove Village 275
Boardman 271
North Bergen 245
Portsmouth 243
Falls Church 237
Pisa 234
Munich 232
Florence 222
Orem 219
Montreal 218
Warsaw 217
Stevenage 215
Ann Arbor 212
Ottawa 212
Beauharnois 193
Jacksonville 192
Brooklyn 185
Mexico City 168
London 162
Frankfurt am Main 161
Toronto 157
Dearborn 156
Atlanta 155
Lawrence 155
Naples 154
Istanbul 150
Tokyo 148
Denver 147
Tel Aviv 146
Sterling 133
Lancaster 130
Stockholm 129
Chennai 126
Miami 126
Poplar 126
Nuremberg 124
Amsterdam 122
Johannesburg 122
Rio de Janeiro 119
Dong Ket 117
Bologna 114
Lappeenranta 107
Da Nang 106
Figino 105
Columbus 103
Turin 100
Boston 99
Haiphong 98
Washington 87
Belo Horizonte 86
Palermo 83
Dulles 79
San Diego 75
Manchester 74
San Francisco 69
Biên Hòa 68
Charlotte 68
Genoa 68
Brasília 67
Turku 67
Detroit 66
Tashkent 66
Quito 65
Ankara 64
Mumbai 61
Totale 45.282
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.860
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.721
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.595
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 907
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 750
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 629
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 504
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 479
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 463
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 463
Echocardiographic and Cardiac Magnetic Resonance Imaging-Derived Strains in Relation to Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy 457
A simple echocardiographic score to rule out cardiac amyloidosis 423
A simple echocardiographic score to rule out cardiac amyloidosis 409
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 382
Building medical knowledge from real world registries: The case of heart failure 378
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 368
Position paper ANMCO: Impiego di vericiguat nello scompenso cardiaco: dalle evidenze al posizionamento terapeutico 361
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 357
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 356
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 347
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 343
Treating chemoreflex in heart failure: modulation or demolition? 334
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 332
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 331
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 330
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 326
Eligibility for vericiguat in a real‐world, contemporary heart failure population 320
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 319
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 313
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 313
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 312
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 311
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 310
[Ten perspectives for research and innovation in cardiac amyloidosis] 310
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 310
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 309
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 309
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 307
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 306
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 305
Screening the health status of people working in a university 303
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 303
RNA-targeting and gene editing therapies for transthyretin amyloidosis 302
How to take arms against central apneas in heart failure 298
Sex-related differences in chronic heart failure 298
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 295
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 293
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 291
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 288
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 287
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 286
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 286
Cardiac light-chain deposition disease relapsing in the transplanted heart 281
Unmet needs in end-of-life care for heart failure patients 280
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 279
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 278
Atrial amyloidosis: mechanisms and clinical manifestations 276
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 274
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 274
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 273
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 269
ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure 269
Biomarkers for the diagnosis and management of heart failure 269
Biomarkers for the diagnosis and management of heart failure: New frontiers 269
Valve disease in cardiac amyloidosis: an echocardiographic score 267
Disease features and management of cardiomyopathies in women 267
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease 267
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides 262
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 261
Assessing cardiac mechanics through left ventricular haemodynamic forces 260
null 258
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 258
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 258
Exercise intolerance in heart failure with preserved ejection fraction: A reappraisal of central mechanisms? 258
null 258
Cardiac magnetic resonance in patients with muscular dystrophies 258
Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure 256
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 255
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 255
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 254
Role of Imaging in Cardiomyopathies 253
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 253
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study 253
Percorsi diagnostico-terapeutici assistenziali per i pazienti con amiloidosi cardiaca – Documento di consenso SIC/ANMCO. A cura della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 253
null 253
Approccio critico all’interpretazione dei trial cardiovascolari con risultati neutri o negativi 252
Factors for heterogeneous outcomes of angina and myocardial ischemia without obstructive coronary atherosclerosis 251
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 247
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 247
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 245
Valvular heart disease in patients with cardiac amyloidosis 244
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study 244
Perspectives in noninvasive imaging for chronic coronary syndromes 244
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 242
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 241
Cardiac troponins as biomarkers for cardiac disease 239
Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis 239
Current and emerging treatment options for transthyretin amyloid cardiomyopathy 237
Effects of sacubitril-valsartan on remodelling, fibrosis and mitochondria in a murine model of isoproterenol-induced left ventricular dysfunction 237
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies 237
Totale 35.443
Salva come PNG Salva come JPEG
Categoria #
all - tutte 389.046
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 389.046
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.001 0 0 0 231 108 145 298 491 203 285 52 188
2022/20231.732 162 165 75 154 210 208 42 155 341 43 121 56
2023/20241.762 107 49 336 122 75 154 106 71 88 96 95 463
2024/202519.231 220 243 878 362 665 803 1.951 3.264 1.352 2.501 4.166 2.826
2025/202642.265 2.174 6.164 4.835 5.507 3.995 2.647 4.115 1.973 2.666 2.793 2.750 2.646
2026/20276.256 1.268 1.410 2.611 967 0 0 0 0 0 0 0 0
Totale 78.217